GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hefei Lifeon Pharmaceutical Co Ltd (SZSE:003020) » Definitions » Equity-to-Asset

Hefei Lifeon Pharmaceutical Co (SZSE:003020) Equity-to-Asset : 0.68 (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Hefei Lifeon Pharmaceutical Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Hefei Lifeon Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Jun. 2024 was ¥1,692 Mil. Hefei Lifeon Pharmaceutical Co's Total Assets for the quarter that ended in Jun. 2024 was ¥2,484 Mil. Therefore, Hefei Lifeon Pharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Jun. 2024 was 0.68.

The historical rank and industry rank for Hefei Lifeon Pharmaceutical Co's Equity-to-Asset or its related term are showing as below:

SZSE:003020' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.46   Med: 0.68   Max: 0.8
Current: 0.68

During the past 11 years, the highest Equity to Asset Ratio of Hefei Lifeon Pharmaceutical Co was 0.80. The lowest was 0.46. And the median was 0.68.

SZSE:003020's Equity-to-Asset is ranked better than
51.95% of 1538 companies
in the Biotechnology industry
Industry Median: 0.67 vs SZSE:003020: 0.68

Hefei Lifeon Pharmaceutical Co Equity-to-Asset Historical Data

The historical data trend for Hefei Lifeon Pharmaceutical Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hefei Lifeon Pharmaceutical Co Equity-to-Asset Chart

Hefei Lifeon Pharmaceutical Co Annual Data
Trend Dec13 Dec14 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.66 0.76 0.78 0.70 0.68

Hefei Lifeon Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.72 0.68 0.69 0.68

Competitive Comparison of Hefei Lifeon Pharmaceutical Co's Equity-to-Asset

For the Biotechnology subindustry, Hefei Lifeon Pharmaceutical Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hefei Lifeon Pharmaceutical Co's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hefei Lifeon Pharmaceutical Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Hefei Lifeon Pharmaceutical Co's Equity-to-Asset falls into.



Hefei Lifeon Pharmaceutical Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Hefei Lifeon Pharmaceutical Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=1685.526/2483.68
=0.68

Hefei Lifeon Pharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

Equity to Asset (Q: Jun. 2024 )=Total Stockholders Equity/Total Assets
=1692.406/2483.905
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hefei Lifeon Pharmaceutical Co  (SZSE:003020) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Hefei Lifeon Pharmaceutical Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Hefei Lifeon Pharmaceutical Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Hefei Lifeon Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.669, Changjiang West Road, Lifang Factory, Anhui Province, Hefei, CHN, 230088
Hefei Lifeon Pharmaceutical Co Ltd is engaged in the research and development, production and sales of pharmaceutical preparations and raw materials, and the wholesale and retail of pharmaceuticals and medical devices. The main industrial products involve cardiovascular drugs, digestive system drugs, external skin drugs, endocrine system drugs, and other fields.
Executives
Wang Qin Supervisors
Wang Qing Directors, executives
Xu Xue Yu Executives

Hefei Lifeon Pharmaceutical Co Headlines

No Headlines